What to Expect ...

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to ...

SAN ANTONIO -- Thoracic surgeons were fired up about minimum expectations for surgical lymph node assessment in conjunction with lung cancer resection during a debate at the Society of Thoracic ...

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to ...

NEW ORLEANS -- More extensive N1 lymph node assessment may better guide therapy after non-small cell lung cancer (NSCLC) resections with curative intent, real-world data suggested. The more N1 ...

Stage 3 non-small cell lung cancer has spread to nearby tissues and lymph nodes but not to more distant tissues. Most people with this stage have lung cancer symptoms. Treatment can depend on several ...

Lung cancer typically spreads locally within the lungs first, migrating through the airways to other areas of the same lung. In some cases, it can then move to the lining of the lung. When lung cancer ...

Small cell lung cancer (SCLC) staging helps doctors determine how advanced the cancer is and choose the best treatment approach. Doctors typically classify SCLC into two stages: limited, where cancer ...

Recent evidence suggests that postoperative adjuvant radiotherapy (PORT) may enhance survival outcomes in patients with pN2 non-small cell lung cancer (NSCLC), particularly when analyzed through ...

Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study We conducted a multicenter, open-label, ...

Upon IAV infection, lung CD8⁺ tissue-resident memory T (TRM) cells upregulate residency-associated gene signatures but exhibit increased apoptosis. A subset of these cells undergoes CCR5–CCL5 ...